These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2877567)

  • 1. Famotidine: clinical applications of a new H2-receptor antagonist. Introduction.
    Texter EC
    Am J Med; 1986 Oct; 81(4B):1-2. PubMed ID: 2877567
    [No Abstract]   [Full Text] [Related]  

  • 2. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California.
    Am J Med; 1986 Oct; 81(4B):1-64. PubMed ID: 2877568
    [No Abstract]   [Full Text] [Related]  

  • 3. [Famotidine. Pharmacologic and clinical profile of the new histamine H2 receptor antagonist].
    Müller P; Dammann HG; Simon B
    Fortschr Med; 1986 Apr; 104(15):319-22. PubMed ID: 2872147
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings of a satellite symposium on famotidine: further developments in H2-receptor antagonist therapy. World Congresses of Gastroenterology meeting. São Paulo, Brazil, 12 September 1986.
    Scand J Gastroenterol Suppl; 1987; 134():1-62. PubMed ID: 2889254
    [No Abstract]   [Full Text] [Related]  

  • 5. Famotidine: an evolution in H2 antagonist therapy. Proceedings of a symposium. São Paulo, Brazil, September 7-12, 1986.
    J Clin Gastroenterol; 1987; 9 Suppl 2():1-27. PubMed ID: 2887612
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of developments in H2-receptor antagonist therapy: focus on famotidine. Proceedings of an official satellite symposium to the 8th Asian-Pacific Congress on Gastroenterology and the 5th Asian-Pacific Congress of Digestive Endoscopy. Seoul, Korea, 10 October 1988.
    J Int Med Res; 1989; 17 Suppl 1():1A-53A. PubMed ID: 2566538
    [No Abstract]   [Full Text] [Related]  

  • 7. The new H2-antagonists--are we prescribing them?
    Gilliland A; Mills K; Steele K
    J R Coll Gen Pract; 1989 Sep; 39(326):387. PubMed ID: 2575170
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of famotidine and ranitidine in duodenal ulcer].
    Rohner HG; Gugler R; Kimmig JM; Schönekäs H
    Dtsch Med Wochenschr; 1987 Feb; 112(9):367-8. PubMed ID: 2880704
    [No Abstract]   [Full Text] [Related]  

  • 9. Famotidine (Pepcid).
    Med Lett Drugs Ther; 1987 Feb; 29(733):17-8. PubMed ID: 2880282
    [No Abstract]   [Full Text] [Related]  

  • 10. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
    Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy intern intervention to reduce costs associated with histamine H2-antagonist therapy.
    Algozzine GJ; Sprenger RL; Caselnova DA; Proper P
    Am J Hosp Pharm; 1989 Jun; 46(6):1183-4. PubMed ID: 2568750
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [24-hour intragastric acid profile in a ZES patient with H2 blockers].
    Dammann HG; Müller P; Simon B; Kommerell B
    Z Gastroenterol; 1984 Jun; 22(6):318-20. PubMed ID: 6147052
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children.
    Miyake S; Yamada M; Iwamoto H; Yamashita S; Sugio Y
    Clin Ther; 1987; 9(5):548-58. PubMed ID: 2889529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double pylorus accompanied by gastric ulcer resistant to H2-receptor antagonist--a case report and review of the literature.
    Yoshimura Y; Yasutake K; Imamura Y; Oimomi M
    Kobe J Med Sci; 1988 Aug; 34(4):151-9. PubMed ID: 2905754
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
    Tomasko MA; Luskin AT
    Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
    [No Abstract]   [Full Text] [Related]  

  • 17. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ; Stables R
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of glucose polymer and an H2-receptor blocker in a patient with a proximal ileostomy.
    Saunders DR; Saunders MD; Sillery JK
    Am J Gastroenterol; 1989 Feb; 84(2):192-4. PubMed ID: 2563628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action of famotidine, a new H2-receptor antagonist, on the papillary muscle and atrium of the guinea pig, in vitro].
    Poli E; Coruzzi G; Bertaccini G
    Cardiologia; 1987 Sep; 32(9):1025-9. PubMed ID: 2891444
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylaxis against acid aspiration syndrome. Single oral dose of H2-antagonist on the evening before elective surgery.
    Gallagher EG; White M; Ward S; Cottrell J; Mann SG
    Anaesthesia; 1988 Dec; 43(12):1011-4. PubMed ID: 2906783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.